Haoxiangni Health Food Co.,Ltd. (SHE:002582)
China
· Delayed Price · Currency is CNY 11.19
-0.28 (-2.44%)
Mar 9, 2026, 3:04 PM CST
Haoxiangni Health Food Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 1,496 | 1,611 | 1,673 | 1,340 | 1,235 | 2,953 | Upgrade
|
| Other Revenue | 58.77 | 58.77 | 54.86 | 60.29 | 46.41 | 48.8 | Upgrade
|
| Revenue | 1,555 | 1,670 | 1,728 | 1,400 | 1,281 | 3,001 | Upgrade
|
| Revenue Growth (YoY) | -14.32% | -3.39% | 23.40% | 9.32% | -57.32% | -49.65% | Upgrade
|
| Cost of Revenue | 1,169 | 1,303 | 1,285 | 1,150 | 955.49 | 2,483 | Upgrade
|
| Gross Profit | 385.62 | 366.68 | 443.66 | 250.72 | 325.63 | 518.27 | Upgrade
|
| Selling, General & Admin | 395.62 | 461.87 | 495.43 | 433.04 | 370.07 | 675.02 | Upgrade
|
| Research & Development | 22.5 | 20.64 | 28.57 | 38.65 | 34.19 | 34 | Upgrade
|
| Other Operating Expenses | 6.66 | 5.06 | 2.95 | 14.16 | 14.88 | 26.9 | Upgrade
|
| Operating Expenses | 430.17 | 493.42 | 531.09 | 517.61 | 420.65 | 758.44 | Upgrade
|
| Operating Income | -44.56 | -126.74 | -87.44 | -266.89 | -95.02 | -240.17 | Upgrade
|
| Interest Expense | -24.03 | -26.68 | -18.5 | -13.58 | -15.82 | -29.18 | Upgrade
|
| Interest & Investment Income | 49.3 | 92.87 | 49.81 | 55.3 | 75.46 | 3,179 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | - | - | 0.11 | -16.57 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.38 | -0.75 | -0.79 | -0.67 | -0.65 | -0.98 | Upgrade
|
| EBT Excluding Unusual Items | -17.92 | -61.31 | -56.92 | -225.84 | -35.92 | 2,892 | Upgrade
|
| Gain (Loss) on Sale of Investments | 19.18 | -8.69 | -1.46 | -0.74 | 79.61 | 3.63 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.65 | -4.53 | -0.33 | 0.01 | 1.3 | -6.36 | Upgrade
|
| Asset Writedown | -5.71 | -5.75 | -2.94 | -29.44 | -8.69 | -57.38 | Upgrade
|
| Other Unusual Items | 4.83 | 4.83 | 10.87 | 21.86 | 30.38 | 80.19 | Upgrade
|
| Pretax Income | -1.26 | -75.44 | -50.78 | -234.17 | 66.68 | 2,912 | Upgrade
|
| Income Tax Expense | 17.38 | 0.27 | 5.76 | -31.32 | 11.75 | 763.61 | Upgrade
|
| Earnings From Continuing Operations | -18.65 | -75.71 | -56.54 | -202.85 | 54.93 | 2,148 | Upgrade
|
| Minority Interest in Earnings | 2.69 | 3.76 | 4.64 | 13.43 | 6.7 | 6.97 | Upgrade
|
| Net Income | -15.96 | -71.96 | -51.89 | -189.42 | 61.63 | 2,155 | Upgrade
|
| Net Income to Common | -15.96 | -71.96 | -51.89 | -189.42 | 61.63 | 2,155 | Upgrade
|
| Net Income Growth | - | - | - | - | -97.14% | 1018.80% | Upgrade
|
| Shares Outstanding (Basic) | 480 | 450 | 432 | 441 | 474 | 502 | Upgrade
|
| Shares Outstanding (Diluted) | 480 | 450 | 432 | 441 | 474 | 502 | Upgrade
|
| Shares Change (YoY) | 15.97% | 4.00% | -1.83% | -7.09% | -5.62% | -0.90% | Upgrade
|
| EPS (Basic) | -0.03 | -0.16 | -0.12 | -0.43 | 0.13 | 4.29 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.16 | -0.12 | -0.43 | 0.13 | 4.29 | Upgrade
|
| EPS Growth | - | - | - | - | -96.97% | 1028.95% | Upgrade
|
| Free Cash Flow | 28.67 | -38.19 | 343.67 | -278.78 | -124.7 | 232.9 | Upgrade
|
| Free Cash Flow Per Share | 0.06 | -0.09 | 0.80 | -0.63 | -0.26 | 0.46 | Upgrade
|
| Dividend Per Share | 1.000 | 1.400 | 0.600 | 0.100 | 0.100 | 1.000 | Upgrade
|
| Dividend Growth | - | 133.33% | 500.00% | - | -90.00% | 1062.79% | Upgrade
|
| Gross Margin | 24.80% | 21.96% | 25.67% | 17.90% | 25.42% | 17.27% | Upgrade
|
| Operating Margin | -2.87% | -7.59% | -5.06% | -19.06% | -7.42% | -8.00% | Upgrade
|
| Profit Margin | -1.03% | -4.31% | -3.00% | -13.53% | 4.81% | 71.80% | Upgrade
|
| Free Cash Flow Margin | 1.84% | -2.29% | 19.89% | -19.91% | -9.73% | 7.76% | Upgrade
|
| EBITDA | 65.48 | -15.77 | 24.78 | -150.58 | 12.74 | -109.44 | Upgrade
|
| EBITDA Margin | 4.21% | -0.94% | 1.43% | -10.75% | 1.00% | -3.65% | Upgrade
|
| D&A For EBITDA | 110.04 | 110.97 | 112.21 | 116.31 | 107.76 | 130.73 | Upgrade
|
| EBIT | -44.56 | -126.74 | -87.44 | -266.89 | -95.02 | -240.17 | Upgrade
|
| EBIT Margin | -2.87% | -7.59% | -5.06% | -19.06% | -7.42% | -8.00% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 17.62% | 26.23% | Upgrade
|
| Revenue as Reported | 1,555 | 1,670 | 1,728 | 1,400 | 1,281 | 3,001 | Upgrade
|
| Advertising Expenses | - | 136.62 | 146.85 | 122.89 | 88.13 | 282.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.